Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 79 recruiting now early-phase tilt #32 of 28,707 conditions

Healthy Volunteers: early-phase trial registry

79 of 284 indexed Healthy Volunteers trials are currently recruiting, with more weight in Phase 1-2.

Corpus placement: #32 of 28,707 conditions by registered trial count.

284 US clinical trials · 79 currently recruiting · #32 of 28,707 conditions by registered trial count

Healthy Volunteers: 284 US clinical trials tracked, 79 recruiting.

Healthy Volunteers is the subject of 284 registered US clinical trials on ClinicalTrials.gov, 79 of them currently open to new participants. 6 are in Phase 3-4 (later-stage) and 206 in Phase 1-2 (earlier-stage). The most active sponsor is Takeda, running 16 of these trials.

Enrollment posture brief

Registry condition healthy-volunteers

OPEN 79 | RECR 28% | LATE 6 | EARLY 206 | RANK #32 | SPON 16

Nearest open-share peer: Arrhythmias, Cardiac (28% recruiting · 18 trials)

Parkinson Disease45.3%Major Depressive Disorder38.5%Pancreatic Cancer35.7%Healthy Volunteers (this)28%Leukemia18.6%
Open-enrollment share among volume-matched conditions near Healthy Volunteers

Healthy Volunteers lists 79 open slots (28% of 284 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Healthy Volunteers on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Healthy Volunteers is recruiting below its size-band peers.

    79 of 284 indexed trials (27.8%) are open to enrollment, against a 37.1% average across 139 conditions with 100+ trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. Sponsorship of Healthy Volunteers trials is spread across many organizations.

    Takeda accounts for 16 of 284 trials (5.6%). 144 distinct sponsors appear on at least one study for this condition label.

  3. Most Healthy Volunteers trials plan to enrol fewer than 100 people.

    Median target enrolment is 48 among the 284 trials that report a genuine target (sentinel values excluded). 204 of those (71.8%) plan for fewer than 100 participants.

  4. Healthy Volunteers research is mostly interventional.

    251 interventional and 33 observational studies make up this index (88.4% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 1198Phase 28Phase 46

Open and recent trials

284 total, page 5 of 6

COMPLETED Phase 1 31 participants

Maribavir Food-Effect Study in Healthy Adults Participants

Takeda

NCT05382104

COMPLETED NA 30 participants

CYP2B6 Polymorphisms in Ketamine

Washington University School of Medicine

NCT01988922

COMPLETED Phase 1 30 participants

Effect of Yohimbine on Colon Transit

Mayo Clinic

NCT00217048

COMPLETED Phase 1 30 participants

Food Effect Study of AG-221 in Healthy Male Subjects

Agios Pharmaceuticals

NCT02218346

COMPLETED Phase 1 30 participants

A Phase I Study to Compare 3 Different Strengths of an Extended Release Formulation of ASP015K to an Immediate Release Formulation of ASP015K

Astellas Pharma Global Development

NCT01686217

COMPLETED Phase 1 30 participants

Study to Assess the Intrapulmonary Pharmacokinetics of SPR859 by Comparing the Plasma, Epithelial Lining Fluid (ELF), and Alveolar Macrophages (AM) Concentrations Following the Oral Administration of Five Doses of SPR994 in Healthy, Nonsmoking Volunteers

Spero Therapeutics

NCT04710407

COMPLETED Phase 1 30 participants

A Study to Assess the Relative Bioavailability and Safety of Different Formulations of AZD4831 in Fasted State in Healthy Volunteers.

AstraZeneca

NCT05457270

COMPLETED Phase 1 28 participants

A Study to Investigate the Bioequivalence of Two Different Forms of Entrectinib (Forms A and C) Under Fasted Conditions in Healthy Subjects

Genentech

NCT03796013

COMPLETED Phase 1 28 participants

A Study About How ASP5354 Affects the Body in Healthy Adults and in Adults Whose Kidneys do Not Work Well

Astellas Pharma Global Development

NCT05495581

COMPLETED Phase 1 27 participants

A Study to Determine the Bioavailability of Vonoprazan Sprinkle Capsules on Pudding or on Applesauce Relative to a Vonoprazan Tablet in Healthy Participants

Phathom Pharmaceuticals

NCT05366738

COMPLETED Phase 1 26 participants

Study of ITI-214 in Healthy Volunteers to Determine CNS Engagement

Intra-Cellular Therapies

NCT03489772

COMPLETED Phase 1 26 participants

Phase 1 Study of ALZT-OP1 Combination Therapy in Normal Healthy Volunteers

AZTherapies

NCT02482324

COMPLETED Phase 1 26 participants

A Study to Compare the Pharmacokinetics and Safety of Mitapivat 100 mg Tablet Formulation With Mitapivat 2 × 50 mg Tablet Formulation in Healthy Adult Participants

Agios Pharmaceuticals

NCT04696393

COMPLETED Phase 1 24 participants

A Study of TAK-227 in Healthy Adults

Takeda

NCT05818956

COMPLETED Phase 1 24 participants

A Study to Assess How Food Affects the Safety and Pharmacokinetics of Galicaftor and Navocaftor

AbbVie

NCT05538585

COMPLETED Phase 1 24 participants

A Study to Assess the Effect Tasimelteon on the Cytochrome P450 3A4 and 2C8 Enzymes in Healthy Subjects

Vanda Pharmaceuticals

NCT01402076

COMPLETED Phase 1 24 participants

A Study to Evaluate Pharmacokinetic, Safety, Tolerability and Relative Bioavailability of Gepotidacin in Healthy Adult Male and Female Participants

GlaxoSmithKline

NCT05271799

COMPLETED Phase 1 24 participants

Effect of Venglustat in Patients With Renal Impairment

Genzyme, a Sanofi Company

NCT03687554

COMPLETED Phase 1 24 participants

A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of C16TR for Inhalation With Tyvaso® Cohort in Healthy Participants

Insmed Incorporated

NCT06193031

COMPLETED Phase 1 24 participants

A Study to Assess the Drug Levels of CC-92480 After Coadministration With Rifampin and Itraconazole, and the Drug Levels of Digoxin and Rosuvastatin After Coadministration With CC-92480 in Healthy Participants

Bristol-Myers Squibb

NCT05389722

COMPLETED Phase 1 24 participants

Food Effect and Bioequivalence Study of Simufilam Tablets in Healthy Volunteers

Cassava Sciences

NCT04932655

COMPLETED Phase 1 24 participants

A Study of TAK-881 in Healthy Adults

Takeda

NCT05059977

COMPLETED Phase 1 24 participants

Drug Interaction Study of Multiple Doses of Isavuconazole and a Single Dose of Bupropion

Astellas Pharma Global Development

NCT01635972

COMPLETED Phase 1 24 participants

Drug Interaction Study of Isavuconazole and Midazolam

Astellas Pharma

NCT01406171

COMPLETED Phase 1 24 participants

Study in Healthy Volunteers of the Bioavailability of Dexpramipexole Tablets and Food Effects

Knopp Biosciences

NCT01607034

COMPLETED Phase 1 24 participants

A Study to Understand How the Study Medicine (PF-07081532) is Processed in People With Liver Dysfunction

Pfizer

NCT05478603

COMPLETED Phase 1 24 participants

A Pilot Study to Compare the Pharmacokinetics (PK) of Single Subcutaneous (SC) Injections of Vedolizumab Administered in Prefilled Syringe (PFS) Versus (vs) Prefilled Syringe in Autoinjector (PFS+AI) in Healthy Participants

Takeda

NCT03961295

COMPLETED Phase 1 24 participants

Effect Of Hepatic Impairment on the Pharmacokinetics, Safety and Tolerability of PF-06865571 In Subjects With Hepatic Impairment and in Healthy Subjects

Pfizer

NCT04091061

COMPLETED Phase 1 22 participants

Drug-drug Interaction Study of CTP-543 and Rifampin in Healthy Adult Subjects

Concert Pharmaceuticals

NCT04843540

COMPLETED Phase 1 22 participants

A Study to Assess Bioequivalence of Fezolinetant Formulations in Healthy Female Participants

Astellas Pharma Global Development

NCT04277624

COMPLETED Phase 1 21 participants

A Study to Learn About How Food and Esomeprazole Affect the Level of BAY2927088 in the Blood When Taken Together in Healthy Participants

Bayer

NCT06378658

COMPLETED Phase 1 20 participants

A Study to Assess Potential Interaction Between ASP8062 and Alcohol in Healthy Adult Subjects

Astellas Pharma Global Development

NCT04003402

COMPLETED 20 participants

Effects of Rosuvastatin on the Immune System in Healthy Volunteers With Normal Cholesterol

National Heart, Lung, and Blood Institute (NHLBI)

NCT01200836

COMPLETED Phase 1 20 participants

Single Oral Dose of 4 mg Cenerimod in Healthy Japanese and Caucasian Subjects

Viatris Innovation

NCT04052360

COMPLETED Phase 1 19 participants

A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Repeat Doses of PF-06372865 in Healthy Subjects

Pfizer

NCT03351751

COMPLETED NA 19 participants

Investigation of Dietary Absorptive Capacity of Fructans in Healthy Subjects - A Dose Response Study

Augusta University

NCT00988403

COMPLETED Phase 1 19 participants

A Study to Evaluate the Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics (PK) of Oral TAK-994 in an Acute Sleep Phase Delay Paradigm in Healthy Male Participants

Takeda

NCT04551079

COMPLETED NA 18 participants

Daily Consumption of Well-Cooked Broccoli May Affect Glucosinolate Metabolites and Inflammatory Biomarkers

USDA Beltsville Human Nutrition Research Center

NCT03013465

COMPLETED Phase 1 18 participants

A Phase 1 Study to Evaluate the Effect of Food on Pharmacokinetics of ASTX029

Astex Pharmaceuticals

NCT04466514

COMPLETED Phase 1 18 participants

Evaluation of the Relative Bioavailability and Food Effect of GDC-9545 in Healthy Females of Non-Childbearing Potential

Genentech

NCT04274075

COMPLETED Phase 1 18 participants

Drug Interaction Study Between Raltegravir And UK-453,061

Pfizer

NCT00784420

COMPLETED Phase 1 18 participants

A Study of RBT-3 in Healthy Volunteers and Volunteers With Stage 3/4 Chronic Kidney Disease

Renibus Therapeutics

NCT04072432

COMPLETED NA 18 participants

E-cigarette Nicotine Pharmacokinetic Study

British American Tobacco (Investments) Limited

NCT03178981

COMPLETED Phase 1 16 participants

Tissue Penetration of Ceftolozane/Tazobactam in Diabetic Patients With Lower Limb Infections

Hartford Hospital

NCT02620774

COMPLETED Phase 1 16 participants

A Study of LY2157299 in Healthy Participants

Eli Lilly and Company

NCT01965808

COMPLETED Phase 1 16 participants

A Study of Evacetrapib and Digoxin in Healthy Participants

Eli Lilly and Company

NCT01897493

COMPLETED 16 participants

Pediatric Microbiome Study With Children Now Approximately 8-10 Years Old.

Johnson & Johnson Consumer Inc. (J&JCI)

NCT03485755

COMPLETED Phase 1 16 participants

Effect of Itraconazole on the Pharmacokinetics of Bardoxolone Methyl in Healthy Adults

Biogen

NCT03264079

COMPLETED NA 16 participants

Metabolic Flexibility as a Biomarker of Adaptation to Diet and Exercise Challenges

USDA Beltsville Human Nutrition Research Center

NCT01987388

COMPLETED Phase 1 16 participants

A Study to Evaluate the Impact of Omeprazole on the Pharmacokinetics of Sotorasib Co-administered With an Acidic Beverage in Healthy Volunteers

Amgen

NCT05497557

← Previous Page 5 of 6 Next →

Phase Distribution

PhaseTrial count
Phase 1 198
Phase 2 8
Phase 4 6

Named interventions

Most-linked intervention names on Healthy Volunteers records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Placebo Drug
38 trials
Placebo Other
8 trials
Midazolam Drug
6 trials
Moxifloxacin Drug
5 trials
Itraconazole Drug
5 trials
Digoxin Drug
4 trials
Isavuconazole Drug
3 trials
Vedolizumab SC Drug
3 trials

US sites by state

Facility locations filed on Healthy Volunteers trials. A trial with sites in several states counts in each.

Maryland 56 trials
Texas 46 trials
Florida 39 trials
California 35 trials
Arizona 22 trials
Wisconsin 13 trials
New Jersey 12 trials
Kansas 11 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Healthy Volunteers page

284 registered trials, 79 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

  • 79 Healthy Volunteers trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
  • Takeda sponsors the most Healthy Volunteers trials on record, review their full trial history before evaluating a specific study. See Takeda's trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Healthy Volunteers condition card totals 284 registered trials; most-linked intervention Placebo; top US site state Maryland. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.